help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Webb, C. B.
Right arrow Articles by Frohman, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Webb, C. B.
Right arrow Articles by Frohman, L. A.

Endocrinology, Vol 113, 1191-1196, Copyright © 1983 by Endocrine Society


ARTICLES

Ectopic growth hormone-releasing factor and dibutyryl cyclic adenosine monophosphate-stimulated growth hormone release in vitro: effects of corticosterone and estradiol

CB Webb, M Szabo and LA Frohman

Glucocorticoids and estrogens each affect GH secretion in vivo. The effects of corticosterone and estradiol (E2) were studied singly and in combination on GH secretion and cell content of primary cultures of rat adenohypophyseal cells grown in media containing intact or hormone- deficient serum. Secretion was measured under basal conditions and in response to maximally stimulatory doses of ectopic GH-releasing factor (E-GHRF) derived from a carcinoid tumor and dibutyryl cAMP [(DBcAMP) 10(-3) M]. Basal GH release measured over a 4-h period was suppressed by 40% (P less than 0.001) when hormone-deficient serum was substituted for normal serum in the growth media, and the stimulatory responses to DBcAMP and E-GHRF were markedly attenuated (P less than 0.001). The GH content of unstimulated cells was also decreased [29 +/- (SE) 7%, P less than 0.001]. The addition of corticosterone, 3 X 10(-8) M to 3 X 10(-6) M, to the 4-day growth media resulted in dose-related increases in basal and DBcAMP-stimulated GH release during the 4-h test period which was proportional to the increases in total cellular GH content. In contrast, corticosterone exposure caused a dose-related enhancement of E-GHRF-stimulated release above that accounted for by the increase in total GH content alone. Concomitant exposure to the releasing stimuli and corticosterone during a 4-h incubation, however, reduced the effects of the releasing stimuli. The addition of E2, 10(-10) M to 10(-8) M, during the 4-day growth period and/or the 4-h stimulation period did not affect the secretion of GH either basally or in response to the stimuli. E2 did increase the cell content of GH, but the effects were not additive to those of corticosterone. These studies indicate that long term (4-day) exposure to corticosterone increases net GH synthesis and E-GHRF-stimulated release, but that acute (4 h) exposure inhibits stimulated release. Although E2 also increases cellular content of GH, it exhibits no demonstrable direct effects on GH secretion or content in the presence of corticosterone.


This article has been cited by other articles:


Home page
EndocrinologyHome page
G. V. Childs, M. Iruthayanathan, N. Akhter, G. Unabia, and B. Whitehead-Johnson
Bipotential Effects of Estrogen on Growth Hormone Synthesis and Storage in Vitro
Endocrinology, April 1, 2005; 146(4): 1780 - 1788.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
I. A. McDuffie, N. Akhter, and G. V. Childs
Regulation of Leptin mRNA and Protein Expression in Pituitary Somatotropes
J. Histochem. Cytochem., February 1, 2004; 52(2): 263 - 273.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. A. Gusenoff, S. M. Harman, J. D. Veldhuis, J. J. Jayme, C. St. Clair, T. Munzer, C. Christmas, K. G. O'Connor, T. E. Stevens, M. F. Bellantoni, et al.
Cortisol and GH secretory dynamics, and their interrelationships, in healthy aged women and men
Am J Physiol Endocrinol Metab, April 1, 2001; 280(4): E616 - E625.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. E. Dean and T. E. Porter
Regulation of Somatotroph Differentiation and Growth Hormone (GH) Secretion by Corticosterone and GH-Releasing Hormone during Embryonic Development
Endocrinology, March 1, 1999; 140(3): 1104 - 1110.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
V. A. Dipippo and C. A. Powers
Tamoxifen and ICI 182,780 Interactions with Thyroid Hormone in the Ovariectomized-Thyroidectomized Rat
J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 142 - 148.
[Abstract] [Full Text]


Home page
ScienceHome page
J. Jansson, T. Downs, W. Beamer, and L. Frohman
Receptor-associated resistance to growth hormone-releasing factor in dwarf "little" mice
Science, April 25, 1986; 232(4749): 511 - 512.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1983 by The Endocrine Society